Caribou Biosciences Company
Caribou Biosciences is a biotechnology company that develops CRISPR technologies and allogenic cell therapies for oncology.
Investors
Investment Stage:
N/A
Headquarters:
Berkeley, California, United States
Founded Date:
2011
Industry:
Biotechnology, Health Care, Therapeutics
Last Funding Date:
2021
Employee Number:
101-250
Investors Number:
28
Technology:
Others
Total Funding:
167549904
Estimated Revenue:
$10M to $50M
Number Of Exists:
1
Investor Type:
Late Stage Venture
Last Funding Type:
Series C
Funding Status:
Late Stage Venture